24.71
price down icon1.89%   -0.475
 
loading
Schlusskurs vom Vortag:
$25.19
Offen:
$25.28
24-Stunden-Volumen:
6.68M
Relative Volume:
0.61
Marktkapitalisierung:
$10.36B
Einnahmen:
$5.06B
Nettoeinkommen (Verlust:
$-2.22B
KGV:
-4.2466
EPS:
-5.82
Netto-Cashflow:
$-3.96B
1W Leistung:
+0.88%
1M Leistung:
-28.80%
6M Leistung:
-54.92%
1J Leistung:
-76.11%
1-Tages-Spanne:
Value
$24.43
$25.28
1-Wochen-Bereich:
Value
$24.26
$27.21
52-Wochen-Spanne:
Value
$23.15
$170.47

Moderna Inc Stock (MRNA) Company Profile

Name
Firmenname
Moderna Inc
Name
Telefon
(617) 714-6500
Name
Adresse
325 BINNEY STREET, CAMBRIDGE
Name
Mitarbeiter
5,800
Name
Twitter
@moderna_tx
Name
Nächster Verdiensttermin
2025-02-14
Name
Neueste SEC-Einreichungen
Name
MRNA's Discussions on Twitter

Vergleichen Sie MRNA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MRNA
Moderna Inc
24.71 10.36B 5.06B -2.22B -3.96B -5.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.10 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.16 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
596.20 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
234.56 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
230.98 26.16B 3.81B -644.79M -669.77M -6.24

Moderna Inc Stock (MRNA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-13 Eingeleitet Citigroup Neutral
2025-02-18 Herabstufung Barclays Overweight → Equal Weight
2025-01-29 Herabstufung Goldman Buy → Neutral
2024-12-18 Herabstufung Argus Buy → Hold
2024-12-10 Fortgesetzt BofA Securities Underperform
2024-11-19 Eingeleitet Berenberg Hold
2024-11-18 Hochstufung HSBC Securities Hold → Buy
2024-11-15 Eingeleitet Wolfe Research Underperform
2024-10-17 Eingeleitet Bernstein Mkt Perform
2024-09-13 Herabstufung JP Morgan Neutral → Underweight
2024-09-13 Herabstufung Jefferies Buy → Hold
2024-09-13 Herabstufung Oppenheimer Outperform → Perform
2024-08-28 Hochstufung HSBC Securities Reduce → Hold
2024-08-07 Hochstufung Deutsche Bank Sell → Hold
2024-08-05 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2024-02-26 Herabstufung HSBC Securities Hold → Reduce
2024-01-02 Hochstufung Oppenheimer Perform → Outperform
2023-11-29 Eingeleitet Canaccord Genuity Hold
2023-11-03 Hochstufung HSBC Securities Reduce → Hold
2023-11-02 Herabstufung Deutsche Bank Hold → Sell
2023-08-04 Herabstufung TD Cowen Outperform → Market Perform
2023-08-03 Herabstufung Deutsche Bank Buy → Hold
2023-07-24 Eingeleitet William Blair Mkt Perform
2023-07-14 Eingeleitet HSBC Securities Reduce
2023-06-26 Hochstufung UBS Neutral → Buy
2023-04-26 Eingeleitet Guggenheim Neutral
2023-03-13 Hochstufung TD Cowen Market Perform → Outperform
2023-03-02 Eingeleitet RBC Capital Mkts Outperform
2023-02-24 Herabstufung SVB Securities Market Perform → Underperform
2022-12-19 Hochstufung Jefferies Hold → Buy
2022-12-14 Herabstufung Chardan Capital Markets Buy → Neutral
2022-10-21 Hochstufung SVB Leerink Underperform → Mkt Perform
2022-09-08 Hochstufung Deutsche Bank Hold → Buy
2022-02-01 Hochstufung Redburn Sell → Neutral
2022-01-26 Hochstufung Deutsche Bank Sell → Hold
2022-01-21 Hochstufung BofA Securities Underperform → Neutral
2022-01-21 Eingeleitet UBS Neutral
2021-12-07 Eingeleitet Cowen Market Perform
2021-11-09 Eingeleitet Wolfe Research Outperform
2021-10-22 Eingeleitet Deutsche Bank Sell
2021-10-15 Hochstufung Piper Sandler Neutral → Overweight
2021-08-06 Herabstufung Oppenheimer Outperform → Perform
2021-08-06 Herabstufung Piper Sandler Overweight → Neutral
2021-07-15 Bestätigt Jefferies Hold
2021-02-01 Herabstufung BofA Securities Neutral → Underperform
2020-12-16 Herabstufung Jefferies Buy → Hold
2020-12-16 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-12-09 Herabstufung Needham Buy → Hold
2020-11-23 Eingeleitet Wells Fargo Equal Weight
2020-11-17 Herabstufung BMO Capital Markets Outperform → Market Perform
2020-09-08 Herabstufung SVB Leerink Mkt Perform → Underperform
2020-07-23 Eingeleitet SVB Leerink Mkt Perform
2020-07-20 Herabstufung JP Morgan Overweight → Neutral
2020-07-13 Eingeleitet Jefferies Buy
2020-06-30 Eingeleitet Argus Buy
2020-06-08 Eingeleitet Barclays Overweight
2020-04-30 Eingeleitet BMO Capital Markets Outperform
2020-03-05 Herabstufung BofA/Merrill Buy → Neutral
2019-12-03 Fortgesetzt BofA/Merrill Buy
2019-10-25 Eingeleitet ROTH Capital Buy
2019-04-05 Eingeleitet Chardan Capital Markets Buy
Alle ansehen

Moderna Inc Aktie (MRNA) Neueste Nachrichten

pulisher
07:40 AM

Moderna sues construction firm claiming leaks, mold at new drug plant - NBC Boston

07:40 AM
pulisher
05:54 AM

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Bank of Montreal Can - MarketBeat

05:54 AM
pulisher
05:39 AM

Bridgewater Associates LP Invests $25.19 Million in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

05:39 AM
pulisher
05:07 AM

Water leaks, mold plague Moderna's new manufacturing site, lawsuit claims - The Business Journals

05:07 AM
pulisher
04:40 AM

Scotia Capital Inc. Decreases Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

04:40 AM
pulisher
02:42 AM

Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

02:42 AM
pulisher
Apr 17, 2025

Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance

Apr 17, 2025
pulisher
Apr 17, 2025

Russell Investments Group Ltd. Has $7.02 Million Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 17, 2025
pulisher
Apr 17, 2025

US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years - Benzinga

Apr 17, 2025
pulisher
Apr 17, 2025

Invesco Ltd. Acquires 979,858 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 17, 2025
pulisher
Apr 17, 2025

Moderna Says New Drug Plant Riddled With Defects, Mold - Law360

Apr 17, 2025
pulisher
Apr 17, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Legal & General Group Plc - MarketBeat

Apr 17, 2025
pulisher
Apr 17, 2025

Moderna (MRNA) Leads Healthcare Short Interest in March - GuruFocus

Apr 17, 2025
pulisher
Apr 17, 2025

Lansdowne Partners UK LLP Acquires New Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 17, 2025
pulisher
Apr 17, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Advisory Services Network LLC - MarketBeat

Apr 17, 2025
pulisher
Apr 17, 2025

Quinn Opportunity Partners LLC Invests $686,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 17, 2025
pulisher
Apr 16, 2025

Neuberger Berman Group LLC Reduces Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 16, 2025
pulisher
Apr 16, 2025

Bloom Energy, Rogers, 3D Systems, Moderna, and EchoStar Stocks Trade Down, What You Need To Know - The Globe and Mail

Apr 16, 2025
pulisher
Apr 16, 2025

Moderna permitted to start commercial mRNA vaccine manufacture in UK - The Pharma Letter

Apr 16, 2025
pulisher
Apr 16, 2025

Leerink Partners Adjusts Moderna Price Target to $23 From $27, Maintains Underperform Rating - MarketScreener

Apr 16, 2025
pulisher
Apr 16, 2025

Moderna Co-Founder and MIT Legend Strengthens Decoy Therapeutics Drug Development Team - Stock Titan

Apr 16, 2025
pulisher
Apr 16, 2025

MRNA Based Vaccines and Therapeutics Therapeutics Market Size - openPR.com

Apr 16, 2025
pulisher
Apr 15, 2025

Renaissance Technologies LLC Purchases 700,458 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 15, 2025
pulisher
Apr 15, 2025

APG Asset Management N.V. Buys 203,792 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 15, 2025
pulisher
Apr 15, 2025

FDA Special Assistant Høeg’s Vaccine Concerns On Display At ACIP - insights.citeline.com

Apr 15, 2025
pulisher
Apr 15, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Shelton Capital Management - MarketBeat

Apr 15, 2025
pulisher
Apr 15, 2025

Goldman Sachs Adjusts Moderna's Price Target to $35 From $49, Keeps Neutral Rating - MarketScreener

Apr 15, 2025
pulisher
Apr 14, 2025

Redburn Atlantic Adjusts Moderna's Price Target to $52 From $55, Keeps Neutral Rating - MarketScreener

Apr 14, 2025
pulisher
Apr 14, 2025

Morgan Stanley Issues Pessimistic Forecast for Moderna (NASDAQ:MRNA) Stock Price - MarketBeat

Apr 14, 2025
pulisher
Apr 13, 2025

Aviva PLC Lowers Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 13, 2025
pulisher
Apr 13, 2025

Resona Asset Management Co. Ltd. Buys Shares of 94,753 Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 13, 2025
pulisher
Apr 13, 2025

Fmr LLC Has $776.08 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 13, 2025
pulisher
Apr 12, 2025

Sit Investment Associates Inc. Sells 10,675 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 12, 2025
pulisher
Apr 12, 2025

Moderna (NASDAQ:MRNA) Sets New 1-Year LowTime to Sell? - MarketBeat

Apr 12, 2025
pulisher
Apr 12, 2025

Lobbying Update: $50,000 of MODERNA US INC. lobbying was just disclosed - Nasdaq

Apr 12, 2025
pulisher
Apr 12, 2025

Aster Capital Management DIFC Ltd Takes Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 12, 2025
pulisher
Apr 12, 2025

RFK Jr Asks If Taxpayer-Funded Healthcare Should Be Accessible To People Smoking 'Three Packs A Day' - Benzinga

Apr 12, 2025
pulisher
Apr 11, 2025

First Week of May 30th Options Trading For Moderna (MRNA) - Nasdaq

Apr 11, 2025
pulisher
Apr 11, 2025

ExodusPoint Capital Management LP Purchases New Shares in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 11, 2025
pulisher
Apr 10, 2025

National Bank of Canada FI Decreases Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Himension Capital Singapore PTE. LTD. Purchases 21,102 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Titleist Asset Management LLC Has $1.31 Million Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Moderna to Report First Quarter 2025 Financial Results on Thursd - GuruFocus

Apr 10, 2025
pulisher
Apr 10, 2025

Schroder Investment Management Group Sells 103,486 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

Novavax (NVAX) Shares Plunge After RFK Jr. Questions Its Covid Vaccine Efficacy - Bloomberg.com

Apr 10, 2025
pulisher
Apr 10, 2025

MRNA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Moderna, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

Is Moderna Stock A Sell After The FDA's 'Bloodbath?' - Investor's Business Daily

Apr 10, 2025
pulisher
Apr 10, 2025

Japan approves Moderna COVID vaccine as booster, Novavax files for 1st approval - tuoitrenews.vn

Apr 10, 2025
pulisher
Apr 10, 2025

Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 - Eagle-Tribune

Apr 10, 2025

Finanzdaten der Moderna Inc-Aktie (MRNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Moderna Inc-Aktie (MRNA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
SAGAN PAUL
Director
Mar 03 '25
Buy
31.76
31,620
1,004,251
312,027
Klinger Shannon Thyme
Chief Legal Officer
Dec 09 '24
Sale
44.68
529
23,637
20,446
$20.04
price up icon 2.51%
$72.65
price up icon 3.49%
$32.60
price up icon 1.27%
$24.61
price up icon 6.77%
$98.76
price up icon 0.52%
biotechnology ONC
$230.98
price up icon 1.24%
Kapitalisierung:     |  Volumen (24h):